An analysis of AI adoption trends in U.S. hospitals through 2025-2026. Examines clinical and operational use cases including ambient AI scribes, Epic's new AI tools, FDA regulatory updates, and ethical considerations in healthcare.
Examines the top 10 programming languages by usage and popularity in the context of AI-assisted coding, analyzing AI tool support (Copilot, Cursor, Claude Code, Amazon Q Developer) and ecosystem maturity with 2025-2026 data.
An analysis of the 2025 healthcare administration job market. Examines key trends, demand drivers, worker shortages, and BLS employment projections.
An analysis of large language model (LLM) diagnostic performance compared to physicians, covering GPT-4o, MedGemma, meta-analyses on LLM-assisted diagnosis, patient trust surveys, and 2025-2026 regulatory developments.
Learn about mechanistic interpretability, named an MIT 2026 Breakthrough Technology. Covers circuit tracing, sparse autoencoders, attribution graphs, and how researchers are reverse-engineering AI models to uncover causal mechanisms within neural networks.
A comprehensive guide to pharmaceutical KPIs for quality, compliance, and operational excellence. Covers metrics for R&D, clinical trials, manufacturing, supply chain, and pharmacovigilance, updated with 2025-2026 regulatory developments including FDA QMM, ICH E6(R3), and ISO 9001:2026.
An analysis of the core technologies and design philosophies of Wolfram Alpha (symbolic AI) and ChatGPT (generative AI), detailing their key differences. Updated for GPT-5.2, Wolfram Language 14.3, and the transition from plugins to Custom GPTs.
This article explains how pill identifier software improves patient safety by accurately identifying medication using physical traits, AI-powered image recognition, and deep learning models achieving over 96% accuracy, preventing costly medical errors.
An educational profile of ZUSDURI, a mitomycin hydrogel for intravesical chemoablation of low-grade, intermediate-risk non-muscle invasive bladder cancer (NMIBC). Updated with 2026 J-code reimbursement, UGN-103 UTOPIA trial results, and commercial launch data.
An analysis of the Medicare program in 2025, detailing the structure and the significant policy impacts of the One Big Beautiful Bill Act (P.L. 119-21).
Examine 2025 trends for Contract Sales Organizations in pharma. This analysis compares top providers and strategies for HCP engagement and outsourcing.
This article explains how AI tools can validate regulatory dossiers, catch technical errors before submission, and minimize rework for emerging biotech companies. Updated with 2025-2026 developments including FDA's ELSA AI assistant, eCTD v4.0 validation updates, McKinsey benchmarks, and the latest Gemini 2.5 vs GPT-5 comparisons.
Examines the evolution of eCTD systems from specialized publishers for regulatory submissions to enterprise platforms that serve as a unified drug lifecycle archive, including the impact of eCTD v4.0, AI-powered RIM tools, and IDMP compliance.
Updated for 2026, this article examines the unique financial challenges facing regional hospitals — including 46% operating at negative margins — and details the accounting practices, software solutions, and AI-driven automation essential for maintaining stability and compliance.
An overview of San Francisco Bay Area neuroscience firms, updated February 2026. Examines companies in neurotechnology, BCIs, and neuropharmacology, with latest clinical trial results, FDA developments, and funding milestones.
A comprehensive overview of AI in pharmacovigilance (updated Feb 2026), covering agentic AI, GenAI-driven case processing, signal detection, CIOMS WG XIV framework, FDA/EMA joint principles, EU AI Act implications, and the latest industry platforms.
An overview of market access analytics covering its definition, scope, and role in helping pharmaceutical firms navigate complex payer reimbursement models. Updated for 2026 with IRA drug price negotiation impacts, agentic AI platforms, EU HTA harmonisation, and digital therapeutics reimbursement advances.
Learn to design, secure, and manage a HIPAA-compliant API. Updated for 2026 with the proposed Security Rule overhaul, mandatory encryption and MFA requirements, and current enforcement trends.
Examines Veeva CRM and Vault CRM adoption across pharma and life sciences as of 2026, covering the Salesforce separation, Vault CRM migration, AI agents, and the competitive dynamics with Salesforce Agentforce Life Sciences.
Learn how WORM (Write Once, Read Many) storage ensures data immutability and integrity for electronic records in the highly regulated biotechnology industry. Updated for 2026 with the latest on EU GMP Annex 11 revisions, SEC 17a-4 audit-trail alternatives, cloud WORM advances, and ransomware defense strategies.
Examine the GPT-5 model family's technical capabilities, ChatGPT Health and ChatGPT for Healthcare launches, applications in life sciences and medicine, and the ethical and regulatory considerations for AI in healthcare. Updated February 2026.
Examines the key scientific journals and trade publications in the pharma and biotech industries, covering peer-review, access models, and target audience.
An educational guide to executing compliant pharmaceutical remarketing. Explores platform policies on Google, Meta, LinkedIn, and Reddit, plus data privacy. Updated for 2025-2026 with Meta's health-data restrictions, FDA enforcement escalation, Google policy changes, and HIPAA tracking updates.
An overview of AI applications in the pharmaceutical sector, from generative AI to ML. Explains key IT management challenges like data, compliance, and security.
© 2026 IntuitionLabs. All rights reserved.
